Haleon (HLN) Interest Expenses (2021 - 2023)
Haleon (HLN) posted Interest Expenses of -$273.1 million for Q4 2023, down 75.97% on a QoQ basis from -$155.2 million in Q2 2023, and down 5719.91% year-over-year from $4.9 million in Q4 2022.
Haleon (HLN) Interest Expenses (2021 - 2023) Analysis & Trends
Haleon's Interest Expenses history runs 3 years deep, the most recent figure standing at -$273.1 million for Q4 2023.
- Quarterly Interest Expenses fell 5719.91% year-over-year to -$273.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2025 was -$273.1 million (up 36.24% YoY) and the FY2025 annual result came in at $448.3 million, down 8.67% from the prior year.
- Interest Expenses was -$273.1 million for Q4 2023 at Haleon, down from -$155.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at -$4.7 million in Q4 2022 and bottomed at -$273.1 million in Q4 2023.
- A 3-year average of -$94.4 million and a median of -$64.1 million in 2021 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses surged 61.33% — and 2023, when it tumbled 5719.91%.
- Haleon's Interest Expenses stood at -$12.1 million in 2021, then jumped by 61.33% to -$4.7 million in 2022, then tumbled by 5719.91% to -$273.1 million in 2023.
- Business Quant data shows HLN's Interest Expenses at -$273.1 million in Q4 2023, -$155.2 million in Q2 2023, and -$116.2 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 258.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -273.05 Mn |
| Dec 31, 2023 | -273.05 Mn |
| Jun 30, 2023 | -155.17 Mn |
| Jun 30, 2023 | -155.17 Mn |
| May 3, 2023 | -116.16 Mn |
| May 3, 2023 | -116.16 Mn |
| Dec 31, 2022 | -4.69 Mn |
| Dec 31, 2022 | -4.69 Mn |
| Sep 20, 2022 | -4.93 Mn |
| Sep 20, 2022 | -4.93 Mn |
| Dec 31, 2021 | -12.13 Mn |
| Dec 31, 2021 | -12.13 Mn |